RxDoctor Payments Data

Benjamin Thomasson, DO

Sports Medicine · Orlando, FLNPI 1396078200

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (48.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Arthrex at 54.2% of the total. Reporting peaked in 2022 at $3,144 and has fallen 79.8% since, to $635 in 2025.

$7,721in general payments, 2019–2025

Across 100 payments — averaging $77.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$4K
  • Stryker$1K
  • Reel Surgical, Inc.$1K
  • Encore Medical, LP$452
  • Vericel Corporation$204
  • Amgen$122
  • plus $152 from 6 others

What the payments were for

  • Travel & lodging$1,67522%
  • Food & beverage$2,29730%
  • Education$3,74949%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex40$4,186
Stryker21$1,406
Reel Surgical, Inc.1$1,200
Encore Medical, LP1$452
Vericel Corporation30$204
Amgen1$122
Tenex Health Inc.1$42
Johnson & Johnson1$32
Zimmer Biomet1$25
Lifenet Health1$22
Smith+Nephew1$18
ERMI LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,721 in reported general payments places this provider in the 75th percentile of 402 sports medicine providers in Florida.

See all sports medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$134,163
Medicare patients
218
Services billed
850

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib87$3,477
Ondansetron OdtOndansetron46$450
Gabapentin109$329
Meloxicam64$208
Ibuprofen20$132
Tramadol Hcl63$74
Ketorolac Tromethamine14$59

Paid to pharmacies, not to this prescriber.

Other sports medicine in Orlando

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →